The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies.  Findings about the efficacy […] Continue reading ->
JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution.   Austria’s Chancellor Sebastian Kurz […] Continue reading ->
Despite a groundswell of growing support, a South African and Indian proposal to the World Trade Organization to suspend patents and other intellectual property on vital COVID-19 vaccines and other health products was put on hold by WTO’s General Council in its session on Monday – with the next debate likely to occur in May.  […] Continue reading ->
The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday.  Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading ->
Leaders of the 27 European Union member states are moving closer to a consensus on an EU-wide system of vaccine certificates for travel between countries in the bloc. Within three months a system will be introduced, EU officials announced on Thursday, the first day of the two-day virtual summit of the European Council. Several EU […] Continue reading ->
A new COVID-19 virus variant recently detected in New York is “surging alarmingly,” according to the authors of two new pre-print studies by two teams of US researchers, from Columbia University and the California Institute of Technology.  Even worse, the new variant, dubbed B.1.526, shares some key mutations in its “spike” protein structure with several […] Continue reading ->
WHO Director General Dr Tedros Adhanom Gheyebresus on Friday issued his strongest call to date for a waiver on intellectual property related to COVID vaccines, medicines and other health products – which is due to be considered next week by the World Trade Organization’s General Council. While welcoming a new UN Security Council resolution also […] Continue reading ->
Over 400 US organisations and 115 Members of the European Parliament declared their support this week for a waiver on intellectual property rights for COVID-19 products, due to be discussed by the World Trade Organisation (WTO) General Council. Even so, WTO insiders said that consensus was more likely to build around a “third way” approach […] Continue reading ->
Ghana’s President, Nana Akufo-Addo, will be publicly vaccinated with the Oxford/AstraZeneca SARS-CoV2 vaccine on 2 March, signifying the start of the West African country’s vaccine rollout. On Wednesday, Ghana became the first country in the world to receive vaccines via the global vaccine access platform, COVAX, according to Health Policy Watch. The Ivory Coast is expected […] Continue reading ->
The largest peer reviewed study to date of some 1.193 million Israelis – half of whom received the Pfizer COVID-19 vaccine – confirms the vaccine’s efficacy in preventing symptomatic COVID-19 as well as serious cases and deaths – even after the first dose is administered. The study, published in the New England Journal of Medicine, […] Continue reading ->